Serotonin 5-HT2A Receptor Antagonists
DBCAT005168Pharmacologic class
Entities that are capable of exerting an antagonistic effect on 5-HT2A receptors. A DrugBank category of 85 drugs. 64 of them are approved.
- Drugs
- Acepromazine
- Amesergide
- Amisulpride
- Amitriptyline
- Amoxapine
- Amperozide
- Aripiprazole
- Aripiprazole lauroxil
- Asenapine
- Blonanserin
- Brexpiprazole
- Bufotenine
- Butriptyline
- Cariprazine
- Carphenazine
- Chlorpromazine
- Chlorprothixene
- Cinitapride
- Clomipramine
- Clozapine
- Cyamemazine
- Cyclobenzaprine
- Cyproheptadine
- Deramciclane
- Desipramine
What you can answer from here — as of July 02, 2020
Which targets do Serotonin 5-HT2A Receptor Antagonists share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account